Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences

Heink, A., Katsikas, S., & Lange-Altman, T. | Journal of Psychoactive Drugs | 7 March 2017

The Iboga Alkaloids

Lavaud, C., & Massiot, G. | Progress in the Chemistry of Organic Natural Products | 1 January 2017

Treating drug dependence with the aid of ibogaine: A qualitative study

Schenberg, E. E., de Castro Comis, M. A., Alexandre, J. F. M., Chaves, B. D. R., Tófoli, L. F., & da Silveira, D. X. | Journal of Psychedelic Studies | 1 January 2017

The antiaddictive effects of ibogaine: A systematic literature review of human studies

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Journal of Psychedelic Studies | 20 December 2016

A One-Dose Psychedelic Fix for Addiction?

Jacobson, R. | Scientific American Mind | 8 December 2016

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016

The Resurrection Of Psychedelic Psychiatry And Its Role In Addiction Treatment

Skocylas, R. | UBC Medical Journal | 1 September 2016

Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. | Experimental and clinical psychopharmacology | 1 July 2016

Ibogaine and addiction in the animal model, a systematic review and meta-analysis

Belgers, M., Leenaars, M., Homberg, J. R., Ritskes-Hoitinga, M., Schellekens, A. F. A., & Hooijmans, C. R. | Translational psychiatry | 31 May 2016

In reply – on the toxicity of ibogaine

Brunt, T. M., & Litjens, R. P. | Clinical toxicology | 31 May 2016

On the toxicity of ibogaine

Yip, L., & Deng, J. F. | Clinical Toxicology | 31 May 2016

Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report

Cloutier-Gill, L., Wood, E., Millar, T., Ferris, C., & Eugenia Socias, M. | Journal of Psychoactive Drugs | 18 May 2016

Treatment of heroin dependence with ibogaine

Schellekens, A., Oosteren, T., Knuijver, T., & Belgers, M. | European Psychiatry | 12 May 2016

Effects of low dose ibogaine on subjective mood state and psychological performance

Forsyth, B., Machado, L., Jowett, T., Jakobi, H., Garbe, K., Winter, H., & Glue, P. | Journal of Ethnopharmacology | 11 May 2016

Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents

Mash, D. C., Ameer, B., Prou, D., Howes, J. F., & Maillet, E. L. | Journal of psychopharmacology (Oxford, England) | 4 April 2016

Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Rubi, L., Eckert, D., Boehm, S., Hilber, K., & Koenig, X. | Cardiovascular Toxicology | 28 March 2016

Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients

Glue, P., Cape, G., Tunnicliff, D., Lockhart, M., Lam, F., Hung, N., ... & Howes, J. | Clinical Pharmacology in Drug Development | 10 February 2016

How toxic is ibogaine?

Litjens, R. P., & Brunt, T. M. | Clinical Toxicology | 25 January 2016

“Herbal seizures” – atypical symptoms after ibogaine intoxication: a case report

Breuer, L., Kasper, B. S., Schwarze, B., Gschossmann, J. M., Kornhuber, J., & Müller, H. H. | Journal of medical case reports | 31 October 2015

[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca]

Szabo, A., Kazai, A., Frecska, E., & Brys, Z. | official journal of the Hungarian Association of Psychopharmacology | 17 September 2015

Noribogaine is a G-Protein Biased κ-Opioid Receptor Agonist

Maillet, E. L., Milon, N., Heghinian, M. D., Fishback, J., Schürer, S. C., Garamszegi, N., & Mash, D. C. | Neuropharmacology | 21 Aug 2015

Noribogaine reduces nicotine self-administration in rats

Chang, Q., Hanania, T., Mash, D. C., & Maillet, E. L. | Journal of Psychopharmacology | 20 May 2015

Ibogan, Tacaman, and Cytotoxic Bisindole Alkaloids from Tabernaemontana. Cononusine, an Iboga Alkaloid with Unusual Incorporation of a Pyrrolidone Moiety

Lim, K. H., Raja, V. J., Bradshaw, T. D., Lim, S. H., Low, Y. Y., & Kam, T. S. | Journal of natural products | 28 April 2015

Mania following use of ibogaine: A case series

Marta, C. J., Ryan, W. C., Kopelowicz, A., & Koek, R. J. | The American Journal on Addictions | 14 April 2015

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., & Johnson, M. W. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 14 March 2015